Alimta Pemetrexed 100mg -500mg Injection

Alimta Pemetrexed 100mg -500mg Injection Specification

Indication
Malignant pleural mesothelioma, Non-small cell lung cancer

Dosage Form
Injection (Lyophilized Powder for Solution)

Salt Composition
Pemetrexed Disodium 100mg / 500mg per vial

Enzyme Types
Not an enzyme (Antineoplastic cytotoxic agent)

Feature
Cytotoxic antineoplastic agent, prescription only

Ingredients
Each vial contains Pemetrexed Disodium

Application
For intravenous infusion after reconstitution

Physical Color/Texture
White to either light yellow or green-yellow lyophilized powder

Fermentation Smell
Odorless

Storage Instructions
Store at 2C to 8C (Refrigerated). After reconstitution, use immediately or store for a short period as per labeling.

Shelf Life
24 months from the date of manufacture

Marketed By
Eli Lilly and Company (India) Pvt Ltd (for Indian market)

Prescription Status
Rx - Sold by retail on the prescription of an oncologist only

Route of Administration
Intravenous infusion only

Caution
Cytotoxic: Handle with care, use appropriate protective equipment

Compatibility
Do not mix with diluents containing calcium, including Lactated Ringer's Injection

Pack Size
Single use vial (100mg and 500mg vial options)

Reconstitution Medium
Sterile 0.9% sodium chloride injection without preservatives

Precautions
Pre-medication with folic acid and vitamin B12 required. To be administered under supervision of a qualified oncologist.

Contraindications
Hypersensitivity to pemetrexed or excipients

About Alimta Pemetrexed 100mg -500mg Injection

Alimta Pemetrexed 100mg -500mg Injection:-

Alimta (Pemetrexed) is a chemotherapy injection used to treat two types of lung cancers: non-small cell lung cancer and mesothelioma, a rare cancer associated with asbestos exposure. This cancer medication works by slowing the growth and spread of cancer cells in the body.

Recommended Dosage - Discount Prescription Drug Alimta

The dosage of Alimta prescribed to each patient will vary. Always follow your physicians instructions and/or the directions on the prescription drug label.

Missed Dose of Alimta

If your physician has instructed or directed you to receive Alimta injection in a regular schedule and you have missed a dose of this medicine, call your doctor as soon as possible.

Highly Targeted Chemotherapy

Alimta Pemetrexed delivers targeted chemotherapy for malignant pleural mesothelioma and non-small cell lung cancer. Its active ingredient, pemetrexed disodium, disrupts cancer cell growth and division. This process requires the intervention of an experienced oncologist, ensuring optimum efficacy and patient safety.

Stringent Preparation and Administration

This medication is supplied as a white to yellow-green lyophilized powder and must be reconstituted only with 0.9% sodium chloride solution. Mixing with diluents containing calcium (such as Lactated Ringers) is strictly prohibited. The infusion should be performed under specialized oncology care due to its cytotoxic nature and prescription status.

Comprehensive Patient Safety Precautions

Prior to treatment, patients must take folic acid and vitamin B12 as pre-medication to minimize adverse effects. Hypersensitivity to pemetrexed or its excipients is a contraindication. Proper storage (at 28C) and careful handling with protective equipment are mandatory for healthcare providers.

FAQs of Alimta Pemetrexed 100mg -500mg Injection:

Q: How should Alimta Pemetrexed Injection be administered?

A: Alimta Pemetrexed Injection must be administered via intravenous infusion only, following reconstitution with sterile 0.9% sodium chloride solution (without preservatives), strictly by a qualified oncologist.

Q: What pre-medications are necessary before using Alimta?

A: Patients are required to take folic acid and vitamin B12 prior to and during treatment to help reduce the risk of severe side effects. Your oncologist will provide specific dosing instructions for these supplements.

Q: When is Alimta Pemetrexed indicated?

A: This medication is approved for the treatment of malignant pleural mesothelioma and non-small cell lung cancer in adults, as determined appropriate by an oncologist.

Q: Where should Alimta Pemetrexed be stored before use?

A: The vials must be kept refrigerated between 2C and 8C. After reconstitution, the solution should be used immediately or according to storage instructions on the packaging.

Q: What is the process for preparing and administering Alimta?

A: A healthcare professional will reconstitute the lyophilized powder with sterile 0.9% sodium chloride (not containing preservatives or calcium), mix gently, and then administer it as an intravenous infusion under close supervision.

Q: What precautions must healthcare providers take with Alimta?

A: Since Alimta is cytotoxic, healthcare workers must handle it with appropriate protective equipment and dispose of materials safely. Administration should only be performed in suitable medical settings.

Q: What are the major benefits of using Alimta Pemetrexed in cancer therapy?

A: Alimta provides a targeted approach to inhibit tumor growth in eligible cancer types, enhancing treatment effectiveness while minimizing toxicity when proper protocols and pre-medications are followed.

Get Latest Price